Eli Lilly Corp. buy Guggenheim
Start price
20.06.25
/
50%
€662.90
Target price
20.06.26
€813.01
Performance (%)
36.30%
Price
21:55
€903.50
Summary
This prediction is currently active. With a performance of 36.30% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 20.06.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 0.922% | 0.922% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $936.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-28.93%
17.08.25
17.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25